4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-074807
Director sold 4,728 shares at $28.16 ($133,140)
- Director acquired 4,094 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Welgus Howard G. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +822 | $6.52 | $5,361 | 36,029 | D |
| 2026-11-16 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,018 | $7.51 | $7,645 | 37,047 | D |
| 2026-11-16 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,254 | $8.63 | $19,452 | 39,301 | D |
| 2026-11-16 | Sale : show line 4 in the form 10b5-1 | −4,728 | $28.16 | $133,140 | 34,573 | D |
| Open-market sales · 4,728 sh · avg $28.16 · $133,140 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −822 | $6.52 | 2029-11-20 | 822 | 4,930 | D |
| 2026-11-16 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −1,018 | $7.51 | 2033-05-31 | 1,018 | 6,108 | D |
| 2026-11-16 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −2,254 | $8.63 | 2034-06-14 | 2,254 | 13,524 | D |
Loading xslF345X06/wk-form4_1795036412.xml…